APTAMERS: THERAPEUTICS, TECHNOLOGIES, AND SERVICES MARKET – THE RISING REALM AMONGST STAKEHOLDERS IN PURSUIT OF ALTERNATIVE THERAPIES TO ANTIBODIES THERAPIES

It has been reported that more than 15 million people in the US suffer from AMD alone with 200,000 cases annually across North America. This indicates a high unmet need of patients thus, paving a way for aptamer-based solutions due to their advantages over traditional antibody-based therapies.

For additional details, please visit:- https://www.rootsanalysis.com/reports/aptamers-therapeutics-technologies-and-services-market.html
 

comments (0)

140 more from jameshebrew